Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
---|---|---|---|
Orchestra BioMed Holdings Inc | OBIO | NASDAQ | Acción Común |
Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
---|---|---|---|---|
5.95 | 5.95 | 7.29 | 6.32 | 5.89 |
Noticias Recientes
Fecha | Hora | Fuente | Noticia |
---|---|---|---|
11/6/2024 | 07:01 | EDGAR2 | Form 8-K - Current report |
03/6/2024 | 15:15 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
27/5/2024 | 23:15 | EDGAR2 | Form EFFECT - Notice of Effectiveness |
24/5/2024 | 15:16 | EDGAR2 | Form 424B3 - Prospectus [Rule 424(b)(3)] |
13/5/2024 | 15:38 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
10/5/2024 | 16:25 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
10/5/2024 | 16:24 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
10/5/2024 | 16:23 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
10/5/2024 | 16:18 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
09/5/2024 | 16:04 | EDGAR2 | Form 424B3 - Prospectus [Rule 424(b)(3)] |
19/9/2023 | 09:19 | DJN | Orchestra BioMed Shares Jump on FDA Nod for BackBeat Study |
19/9/2023 | 07:24 | DJN | Orchestra BioMed Gets FDA Nod for BackBeat Study |